Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-074900
Filing Date
2010-08-09
Accepted
2010-08-09 14:34:49
Documents
17
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g24036e10vq.htm 10-Q 1175873
2 EX-3.1 g24036exv3w1.htm EX-3.1 20142
3 EX-3.2 g24036exv3w2.htm EX-3.2 50753
4 EX-10.1 g24036exv10w1.htm EX-10.1 527097
5 EX-10.2 g24036exv10w2.htm EX-10.2 22566
6 EX-10.3 g24036exv10w3.htm EX-10.3 50381
7 EX-10.4 g24036exv10w4.htm EX-10.4 46430
8 EX-31.1 g24036exv31w1.htm EX-31.1 9037
9 EX-31.2 g24036exv31w2.htm EX-31.2 9029
10 EX-32.1 g24036exv32w1.htm EX-32.1 3716
11 EX-32.2 g24036exv32w2.htm EX-32.2 3708
  Complete submission text file 0000950123-10-074900.txt   6020603

Data Files

Seq Description Document Type Size
12 EX-101 INSTANCE DOCUMENT kg-20100630.xml EX-101.INS 950459
13 EX-101 SCHEMA DOCUMENT kg-20100630.xsd EX-101.SCH 15194
14 EX-101 CALCULATION LINKBASE DOCUMENT kg-20100630_cal.xml EX-101.CAL 39615
15 EX-101 LABELS LINKBASE DOCUMENT kg-20100630_lab.xml EX-101.LAB 131849
16 EX-101 PRESENTATION LINKBASE DOCUMENT kg-20100630_pre.xml EX-101.PRE 84461
17 EX-101 DEFINITION LINKBASE DOCUMENT kg-20100630_def.xml EX-101.DEF 18778
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15875 | Film No.: 101001114
SIC: 2834 Pharmaceutical Preparations